Evidence map›Paper›PMID 34617704›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2021

Clinical and epidemiological characteristics of patients hospitalized for SARS-CoV-2 infection in two hospitals in Córdoba.

Emanuel José Saad, María Antonella Correa Barovero, Federico Ariel Marucco, Silvina Trinidad Rodríguez Bonazzi, Ayelén Tarditi Barra, Melani Zlotogora, Sofía María Villada, Augusto Douthat Y Barrionuevo, María Celeste Heredia, Juan Pablo Caeiro and 2 more

Abstract read
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Performance of prognostic scores during the first and second waves of COVID-19 pneumonia]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emanuel José SaadHospital Privado universitario de Córdoba. emanuelsaad@hotmail.com.
María Antonella Correa BaroveroHospital Privado Universitario de Córdoba. antocorrea77@gmail.com.
Federico Ariel MaruccoHospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. fedemarucco79@gmail.com.
Silvina Trinidad Rodríguez BonazziHospital Privado Universitario de Córdoba. silvitrb@gmail.com.
Ayelén Tarditi BarraHospital Privado Universitario de Córdoba. ayetarditi@gmail.com.
Melani ZlotogoraHospital Privado Universitario de Córdoba. melizloto@gmail.com.
Sofía María VilladaHospital Privado Universitario de Córdoba. sofivillada14@gmail.com.
Augusto Douthat Y BarrionuevoHospital Privado Universitario de Córdoba. douthataug@gmail.com.
María Celeste HerediaHospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. celesteheredia62@gmail.com.
Juan Pablo CaeiroHospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. jpcaeiro3@gmail.com.
Pehuén FernándezHospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba. pehuenfernandez@hotmail.com.
Ricardo Arturo AlbertiniHospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba. ricartualbertini@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 disease shows a marked heterogeneity in its clinical course, with descriptions of some factors associated with a worse prognosis. Knowledge of the disease behavior in the local scenario is relevant to allow a better approach. Methods: Retrospective study in two hospitals in the city of Córdoba, Argentina, with patients aged 18 years or more, hospitalized for active SARS-CoV-2 infection, from March to October, 2020. Results: 448 patients were included, of which 95.75% corresponded to COVID-19 pneumonia. Most of the episodes occurred in men (63.6%), the median age was 63 years (IQR: 53-75), and the most frequent comorbidities were arterial hypertension (55.1%), obesity (31.7%) and diabetes mellitus (28.1%). 162 patients (36.2%) needed admission to the intensive care unit and 66 (14.7%) were placed on mechanical ventilation. 67 patients (15%) died within the first 30 days of follow-up. In the multivariate analysis, the only independent variable predictive of mortality at 30 days was age (adjusted Odds ratio [aOR] = 1.08, 95% CI = 1.04-1.11, p <0.001). The 4C-Score and CALL-Score prognostic scores showed good discrimination (Area under the curve [AUC] = 0.766, 95% CI = 0.72-0.80 and AUC = 0.785, 95% CI = 0.70-0.85 respectively) and the predicted percentages of mortality were quite close to what was observed in the present study. Conclusions: Most of the patients hospitalized with SARS-CoV-2 infection presented comorbidities and were admitted with pneumonia, associated with high mortality. The prognostic scores with the best performance to predict complications were the 4C-score and the CALL-score.

Indexed as

COVID-19SARS-CoV-2ArgentinaHospitalsHumansbetacoronaviruscoronavirus infectionsinpatientspneumoniaprognosis

Identifiers

PMID34617704
PMCPMC8760912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.